Astrana Health, Inc. (ASTH) vs Palvella Therapeutics, Inc. (PVLA)

A side-by-side comparison of Astrana Health, Inc. and Palvella Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ASTH vs PVLA

growth of $100 · dividends reinvested · last 2y
ASTH -6.7% (-3.4%/yr)PVLA +677.4% (+178.8%/yr)PVLA compounded faster over this window
Log scale — wide-divergence pair
101001kStart $10020252026$93$777
ASTH PVLA

ASTH vs PVLA: by the numbers

  • •PVLA is the larger company ($1.84B vs $1.83B market cap).
  • •ASTH is profitable (1.05% net margin) while PVLA runs a net loss (0.00%).

Metrics side by side

Valuation

MetricASTHPVLA
P/E ratio45.26N/A
Forward P/E26.47N/A
P/S ratio0.48N/A
P/B ratio2.218.47
EV / EBITDA13.48N/A
FCF yield8.64%N/A

Profitability

MetricASTHPVLA
Gross margin9.22%0.00%
Operating margin2.61%0.00%
Net margin1.05%0.00%
ROE4.88%-28.45%
ROIC4.13%-23.90%

Growth (annualized)

MetricASTHPVLA
Revenue CAGR (5Y)53.77%N/A
EPS CAGR (5Y)-15.06%N/A
FCF CAGR (5Y)18.35%N/A
Total return CAGR (5Y)-16.52%N/A

Frequently asked

Is ASTH or PVLA more profitable?
ASTH runs the higher net margin — ASTH at 1.05% versus PVLA at 0.00%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.